RGS RGS Healthcare Solutions

Resource

Medicine buyers in Europe: who tenders, country by country

Published 2026-11-08 · Updated 2026-11-16 · RGS Healthcare Solutions

Short answer: In most European countries, hospital medicines are bought by regional or national purchasing bodies and hospital groups. Germany and the Netherlands add health insurers for outpatient generics, and Denmark, Norway, Portugal and Greece buy largely through one national body. The table lists the main buyers and award models per market, with a link to each market guide.

How to read the table

Each row summarises one market guide. Buyers are the organisations that run tenders, not the sites where tenders are published. The award model shows whether a lot usually has one winner or several, which decides how results should be read.

Main medicine buyers by market

MarketMain buyersAward model
GermanyStatutory health insurers (AOK, TK, BARMER, DAK, IKK and BKK groups); hospital purchasing groups; public university and municipal hospitalsLowest price per lot; many insurers award up to three partners per lot
FranceUniHA, Resah and AGEPS (AP-HP); regional hospital groups (GHT); UGAP for some categoriesMulti-criteria: price with quality, supply security and service, plus at least one environmental criterion since August 2026
ItalyRegional central purchasing bodies (for example ARIA, SoReSa, Intercent-ER, ESTAR, Azienda Zero); local health authorities and hospitals below the thresholdMostly lowest price, some quality-price awards; biosimilar frameworks ranked, with patients treated with one of the first three
SpainINGESA (national centralised purchasing); regional health services such as SAS, SERMAS, CatSalut and ICS, Osakidetza and SERGAS; individual hospitalsMulti-criteria, typically price plus quality, service and sustainability criteria
NetherlandsHealth insurers for outpatient medicines; hospitals and hospital purchasing groups for inpatient and specialist medicinesLowest price for preference policy; hospital tenders often multi-criteria
BelgiumIndividual hospitals and loco-regional hospital networks; joint tenders between hospitalsMulti-criteria, with price, quality and service; several criteria are banned for biologicals
United KingdomNational NHS commercial teams (the Commercial Medicines Unit) for hospital medicines; NHS Supply Chain for devices and consumables; NHS National Services Scotland; NHS Wales Shared Services PartnershipPrice with service and supply criteria; England often multi-supplier per line by region, Scotland single or unranked multi-supplier
NordicsAmgros (Denmark); Sykehusinnkjøp HF (Norway); the Swedish regions, often jointly by healthcare region; Finnish wellbeing services counties and their joint purchasing unitsPrice-led, with environmental and supply criteria playing a growing role
Austria and SwitzerlandAustria: the state hospital operators and the Bundesbeschaffung GmbH (BBG) for selected medicines. Switzerland: cantonal and university hospitals and their purchasing groupsAustria: mostly lowest price. Switzerland: price with quality and supply criteria
Portugal, Ireland and GreecePortugal: SPMS and the 39 local health units (ULS) formed in 2024. Ireland: the Health Service Executive. Greece: EKAPY and public hospitalsMostly price-led
Central and Eastern EuropeIndividual public hospitals; national central purchasing in Romania and Hungary; the health insurers in Czechia from 2026Predominantly lowest price

Questions

Who buys hospital medicines in Europe?

Mostly regional or national purchasing bodies and hospital groups, plus individual hospitals for smaller purchases. The mix differs by country: Italy buys through regional central bodies, France through national purchasing groups, Denmark through one national body.

How each market does it

Terms used in this guide

See the answer on your own molecules

We load your products and markets before the demo, and show the results for them.